Literature DB >> 2937808

Role of atrial natriuretic peptide in adaptation of sodium excretion with reduced renal mass.

S Smith, S Anderson, B J Ballermann, B M Brenner.   

Abstract

The kidney maintains constancy of body fluid volume by regulating urinary sodium (Na) excretion. In chronic renal failure, the reduction in glomerular filtration rate (GFR) is accompanied by an increase in Na excretion per nephron if dietary Na intake is not changed. Reduction in Na intake in proportion to reduced GFR obviates this adaptive increase in tubule Na excretion. To examine the potential role of endogenous atrial natriuretic peptide (ANP) in modulating the enhanced Na excretion per nephron in chronic renal failure, we studied rats subjected to 5/6 nephrectomy or sham operation on low, normal, and high Na intakes. Urinary Na excretion increased with increasing dietary Na in all groups, and Na excretion per nephron was increased in 5/6 nephrectomized rats as compared with sham-operated rats on the higher Na intakes. Plasma ANP levels were unaffected by dietary Na manipulations in sham-operated rats, but rose progressively in 5/6 nephrectomized rats with increasing Na intake. Despite extensive nephron reduction, however, plasma ANP levels failed to rise in uremic rats on low Na diets and in this group Na excretion per nephron also failed to rise. We conclude that enhanced ANP secretion may play an important role in promoting the adaptive increase in Na excretion per nephron in chronic renal failure. Restriction of dietary Na in the setting of reduced GFR obviates the stimulation of ANP secretion as well as the adaptive increase in Na excretion rate per nephron.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2937808      PMCID: PMC424506          DOI: 10.1172/JCI112447

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  14 in total

Review 1.  The regulation of extracellular fluid volume.

Authors:  O H Gauer; J P Henry; C Behn
Journal:  Annu Rev Physiol       Date:  1970       Impact factor: 19.318

2.  A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats.

Authors:  A J de Bold; H B Borenstein; A T Veress; H Sonnenberg
Journal:  Life Sci       Date:  1981-01-05       Impact factor: 5.037

Review 3.  Functional adaptation to reduction in renal mass.

Authors:  J P Hayslett
Journal:  Physiol Rev       Date:  1979-01       Impact factor: 37.312

4.  On the adaptation in sodium excretion in chronic uremia. The effects of "proportional reduction" of sodium intake.

Authors:  R W Schmidt; J J Bourgoignie; N S Bricker
Journal:  J Clin Invest       Date:  1974-06       Impact factor: 14.808

5.  Intrarenal localization of the natriuretic effect of cardiac atrial extract.

Authors:  H Sonnenberg; W A Cupples; A J de Bold; A T Veress
Journal:  Can J Physiol Pharmacol       Date:  1982-09       Impact factor: 2.273

6.  Atrial natriuretic factor in rat hypothalamus, atria and plasma: determination by specific radioimmunoassay.

Authors:  I Tanaka; K S Misono; T Inagami
Journal:  Biochem Biophys Res Commun       Date:  1984-10-30       Impact factor: 3.575

7.  Studies on the characteristics of the control system governing sodium excretion in uremic man.

Authors:  E Slatopolsky; I O Elkan; C Weerts; N S Bricker
Journal:  J Clin Invest       Date:  1968-03       Impact factor: 14.808

8.  Atriopeptin III. A potent natriuretic, diuretic, and hypotensive agent in rats with chronic renal failure.

Authors:  B R Cole; M A Kuhnline; P Needleman
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

9.  Atrial natriuretic factor--a circulating hormone stimulated by volume loading.

Authors:  R E Lang; H Thölken; D Ganten; F C Luft; H Ruskoaho; T Unger
Journal:  Nature       Date:  1985 Mar 21-27       Impact factor: 49.962

10.  Renal mechanism of action of rat atrial natriuretic factor.

Authors:  C L Huang; J Lewicki; L K Johnson; M G Cogan
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

View more
  10 in total

1.  The effects of low dose intravenous 99-126 atrial natriuretic factor infusion in patients with chronic renal failure.

Authors:  A S Woolf; M A Mansell; B I Hoffbrand; S L Cohen; P J Moult
Journal:  Postgrad Med J       Date:  1989-06       Impact factor: 2.401

2.  Atrial natriuretic peptide and sodium homeostasis in chronic renal failure.

Authors:  T Tulassay; W Rascher; K Schärer
Journal:  Pediatr Nephrol       Date:  1989-10       Impact factor: 3.714

3.  Myogenic responses of mouse isolated perfused renal afferent arterioles: effects of salt intake and reduced renal mass.

Authors:  En Yin Lai; Maristela L Onozato; Glenn Solis; Shakil Aslam; William J Welch; Christopher S Wilcox
Journal:  Hypertension       Date:  2010-03-01       Impact factor: 10.190

4.  High-salt diet induces outward remodelling of efferent arterioles in mice with reduced renal mass.

Authors:  L Zhao; Y Gao; X Cao; D Gao; S Zhou; S Zhang; X Cai; F Han; C S Wilcox; L Li; E Y Lai
Journal:  Acta Physiol (Oxf)       Date:  2016-08-15       Impact factor: 6.311

Review 5.  Torasemide in advanced renal failure.

Authors:  J Kindler
Journal:  Cardiovasc Drugs Ther       Date:  1993-01       Impact factor: 3.727

6.  Atrial natriuretic hormones--thirty years after the discovery of atrial volume receptors.

Authors:  H J Kramer; B Lichardus
Journal:  Klin Wochenschr       Date:  1986-08-15

7.  Atrial natriuretic peptide (ANP) in patients with chronic renal failure on maintenance haemodialysis.

Authors:  R de Châtel; J Makó; M Tóth; I Barna; R E Lang
Journal:  Int Urol Nephrol       Date:  1991       Impact factor: 2.370

Review 8.  Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update.

Authors:  Raymond Vanholder; Anneleen Pletinck; Eva Schepers; Griet Glorieux
Journal:  Toxins (Basel)       Date:  2018-01-08       Impact factor: 4.546

9.  Differential effects of commercial-grade and purified poloxamer 188 on renal function.

Authors:  Martin Emanuele; Balu Balasubramaniam
Journal:  Drugs R D       Date:  2014-06

10.  Atrial natriuretic peptide protects vertebral endplate chondrocytes against H2O2‑induced apoptosis and oxidative stress through activation of the Nrf2/HO‑1 signaling pathway.

Authors:  Feiping He; Jingying Gai; Jun Wang; Lei Tang; Yifeng Liu; Qingchun Feng
Journal:  Mol Med Rep       Date:  2021-09-03       Impact factor: 2.952

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.